DiamiR is a molecular diagnostic company that specializes in brain health. It develops blood-based tests for early detection and monitoring of Alzheimer’s, Parkinson’s, and cancer. The company uses technology that is based on quantitative analysis of circulating organ-enriched miRNAs in plasma and can be used for screening, patient stratification as well as disease and treatment monitoring.